Showing results (1291-1300 of 5,146) with videos related to

Sort By:
Pageof 515
Multiple Sclerosis and Related Disorders|January 16, 2023
Comparative pharmacokinetics and bioavailability of monomethyl fumarate following a single oral dose of Bafiertam® (monomethyl fumarate) versus Vumerity® (diroximel fumarate)Franck S Rousseau, Laurene Wang, Tiffany N Sprague, et al.
Multiple Sclerosis and Related Disorders|January 9, 2023
Significant retinal microvascular impairments in multiple sclerosis assessed through optical coherence tomography angiographyXuejiao Wang, Xuqian Wang, Yuyu Chou, et al.
Multiple Sclerosis and Related Disorders|December 22, 2022
The effect of therapeutic exercise on depressive symptoms in people with multiple sclerosis - A systematic reviewGeorgios Marios Kyriakatis, Thomas Besios, Prokopia Mirka Lykou
Multiple Sclerosis and Related Disorders|December 22, 2022
JCV seroconversion rate during the SARS COVID-19 pandemicI Vigiser, Y Piura, H Kolb, et al.
Multiple Sclerosis and Related Disorders|December 22, 2022
OCT and VEP correlate to disability in secondary progressive multiple sclerosisAnna Eklund, Yumin Huang-Link, Beatrix Kovácsovics, et al.
Multiple Sclerosis and Related Disorders|December 22, 2022
New, diagnostic flicker test for optic neuritis shows specific stages following disease onsetGorm Pihl-Jensen, Susanne Trauzettel-Klosinski, Benedikte Wanscher, et al.
Multiple Sclerosis and Related Disorders|December 22, 2022
Quantifying lower extremity inter-segmental coordination variability during walking in people with multiple sclerosis with high and low fear of fallingRazieh Mofateh, Reza Salehi, Mohammad Mehravar, et al.
Multiple Sclerosis and Related Disorders|December 22, 2022
Humoral efficacy of the third SARS-CoV-2 vaccine dose in Multiple Sclerosis subjects undergoing different disease-modifying therapiesGiorgia Teresa Maniscalco, Antonietta Liotti, Anne Lise Ferrara, et al.
Multiple Sclerosis and Related Disorders|June 14, 2022
Prevalence, incidence, and season distribution of MOG antibody-associated disease in the province of Verona, ItalyRiccardo Orlandi, Sara Mariotto, Alberto Gajofatto
Multiple Sclerosis and Related Disorders|June 6, 2022
Blood-brain barrier permeability changes in the first year after alemtuzumab treatment predict 2-year outcomes in relapsing-remitting multiple sclerosisMaria Højberg Knudsen, Ulrich Lindberg, Jette Lautrup Frederiksen, et al.
Pageof 515